NovoCure Limited (NVCR)
(Delayed Data from NSDQ)
$21.50 USD
-0.65 (-2.93%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $21.51 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum C VGM
Brokerage Reports
NovoCure Limited [NVCR]
Reports for Purchase
Showing records 121 - 140 ( 211 total )
Company: NovoCure Limited
Industry: Medical Services
1Q19; Optune Doing Just Fine as Three Key Regulatory Catalysts Loom Over 2019
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Company: NovoCure Limited
Industry: Medical Services
Company: NovoCure Limited
Industry: Medical Services
CAC Got the Feels for Tumor Treating Fields?
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
FY18 Financials; Optune Closing in on Medicare Reimbursement
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
Biotechnology - AACR Abstract Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Company: NovoCure Limited
Industry: Medical Services
Company: NovoCure Limited
Industry: Medical Services
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
Prelim Q4 Optune Metrics Positive, Medicare Coverage on the Horizon in 2019
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
3Q18; Progress toward Medicare Reimbursement, Market and Label Expansion
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
STELLAR Presentation at IASLC leaves us Confident for Registration
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
Company: NovoCure Limited
Industry: Medical Services
Company: NovoCure Limited
Industry: Medical Services
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: NovoCure Limited
Industry: Medical Services
Stellar STELLAR Results Prove Commercial Potential Beyond GBM
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D